跳至主要内容
临床试验/CTRI/2024/04/066435
CTRI/2024/04/066435尚未招募4 期

A Study of the Efficacy and Safety of Combination of Omega-3 Fatty Acids and Vitamin E versus Combined Oral Contraceptive Pills in Polycystic Ovarian Syndrome - NI

Pandit B. D. Sharma UHS Rohtak0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Females of age group (15-45 years).
  • 2.Subjects diagnosed with PCOS according to modified 2018 criteria (Rotterdam criteria): Presence of 2 out of 3 traits.
  • a.v Presence of Hyperandrogenism (clinical and/or biochemical)
  • b.v Oligo/Anovulation
  • c.v PCOM (Polycystic ovarian morphology)- at least one ovary with
  • i=20 follicles per ovary in either ovary
  • ii=10 cm3 of ovarian volume
  • 3.Patients willing to give written informed consent/assent.

排除标准

  • 1.Any history of Neoplastic disease.
  • 2.Endocrinal disorders like Hyperprolactinemia, Hyper/ Hypo Thyroidism and Acromegaly.
  • 3.Functional Hypothalamic amenorrhoea.
  • 4.Already on PCOS treatment or have taken Vitamin supplements in the last 3 months.
  • 5.Females who are either pregnant, willing to become pregnant or lactating.
  • 6.Any Chronic Liver or renal disease.

研究者

发起方
Pandit B. D. Sharma UHS Rohtak

相似试验

已完成
不适用
Investigation on efficacy and safety of combination treatment with imidafenacin and mirabegron in patients with overactive bladder.overactive bladder
JPRN-UMIN000016236Clinical Research Support Center Kyushu30
已完成
2 期
A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel with MORAb-004 in Metastatic Soft Tissue Sarcomasoft tissue cancer10072990
NL-OMON39691Morphotek, Inc10
进行中(未招募)
1 期
A clinical trial that is evaluating how safe and effective an experimental treatment called MORAb-004 is when used in combination with Gemcitabine and Docetaxel in patients diagnosed with Metastatic Soft Tissue Sarcoma.
EUCTR2012-001399-12-NLMorphotek Inc.200
进行中(未招募)
1 期
A clinical trial that is evaluating how safe and effective an experimental treatment called MORAb-004 is when used in combination with Gemcitabine and Docetaxel in patients diagnosed with Metastatic Soft Tissue Sarcoma.Metastatic Soft Tissue SarcomaMedDRA version: 15.1Level: HLGTClassification code 10041299Term: Soft tissue sarcomasSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-001399-12-BEMorphotek Inc.200
已完成
不适用
Effect of the combination of artificial dura and umbilical cord and placenta mesenchymal stem cell-derived exosomes in patients with complete spinal cord injuryComplete spinal cord injury.Injury of spinal cord, level unspecifiedT09.3
IRCT20200502047277N1Shahid Beheshti University of Medical Sciences60